Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kindred Biosciences (KIN)

Kindred Biosciences (KIN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 420,524
  • Shares Outstanding, K 45,462
  • Annual Sales, $ 42,160 K
  • Annual Income, $ -21,800 K
  • 60-Month Beta 1.30
  • Price/Sales 9.97
  • Price/Cash Flow N/A
  • Price/Book 5.27
Trade KIN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.03
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 08/04/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.17
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.25
  • Prior Year -0.31
  • Growth Rate Est. (year over year) +45.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.05 +2.21%
on 07/29/21
9.26 -0.11%
on 08/27/21
+0.17 (+1.87%)
since 07/27/21
3-Month
4.64 +99.31%
on 06/01/21
9.28 -0.32%
on 06/17/21
+4.46 (+93.11%)
since 05/27/21
52-Week
3.46 +167.34%
on 11/02/20
9.28 -0.32%
on 06/17/21
+5.30 (+134.18%)
since 08/27/20

Most Recent Stories

More News
TCW Special Purpose Acquisition Corp. Appoints Nanxi Liu to Board of Directors

TCW Special Purpose Acquisition Corp. (NYSE: TSPQ), a $464 million blank check company sponsored by The TCW Group, Inc. (“TCW”), announced that it has appointed Nanxi Liu to the Company’s Board of...

TSPQ : 10.02 (+0.02%)
PRTS : 1.6200 (-1.82%)
KIN : 9.25 (+0.11%)
ELAN : 16.28 (+0.68%)
Proactive news headlines including Arrow Minerals, Technology Metals Australia, High Peak Royalties and Marvel Gold

Sydney, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

AMD : 180.49 (+0.50%)
HPR : 4.73 (-13.53%)
CXO : 65.60 (-6.02%)
PNX : 37.49 (+0.05%)
BUR : 15.97 (-0.50%)
CVS : 79.76 (+0.42%)
KIN : 9.25 (+0.11%)
PDI : 19.29 (+0.31%)
PNR : 85.44 (+0.49%)
Proactive news headlines including Perpetual Resources, West Wits Mining, K2fly and Greenland Minerals

Sydney, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

IMCC.CN : 0.6300 (+10.53%)
LEG : 19.15 (+1.00%)
KIN : 9.25 (+0.11%)
ARE : 128.91 (+0.96%)
CPT : 98.40 (+1.28%)
Proactive news headlines including Great Boulder Resources, Pan Asia Metals, Chimeric Therapeutics and archTIS

Sydney, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

GBR : 1.0500 (-0.94%)
PAM : 43.14 (-0.83%)
LYL : 0.5004 (-9.02%)
BRK : 193.01 (-0.41%)
KIN : 9.25 (+0.11%)
BDC : 92.61 (-0.64%)
INVESTIGATION: Halper Sadeh LLP Investigates SYKE, MCF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Sykes Enterprises, Incorporated (NASDAQ:SYKE) concerning...

SYKE : 54.00 (+0.04%)
MCF : 3.22 (+3.54%)
ONEM : 16.47 (+2.87%)
KIN : 9.25 (+0.11%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, VNE, ACBI, KIN; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RFL : 1.7200 (unch)
VNE : 36.95 (+0.19%)
ACBI : 32.34 (-0.09%)
KIN : 9.25 (+0.11%)
Lifshitz Law Firm, P.C. Announces Investigation of BRBS, IRT, KIN, and MMAC

NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) --

BRBS : 2.69 (+2.28%)
IRT : 16.13 (+0.75%)
KIN : 9.25 (+0.11%)
MMAC : 27.77 (+0.04%)
INVESTIGATION: Halper Sadeh LLP Investigates LONE, KIN, GRA, ADXS; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 22, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Lonestar Resources US Inc. (OTCQX:LONE) concerning...

LONE : 16.0000 (+6.24%)
KIN : 9.25 (+0.11%)
GRA : 69.99 (+0.03%)
ADXS : 0.6400 (-8.57%)
Lifshitz Law Firm, P.C. Announces Investigation of BRBS, KIN, MMAC, and GRA

NEW YORK, July 21, 2021 (GLOBE NEWSWIRE) --

BRBS : 2.69 (+2.28%)
KIN : 9.25 (+0.11%)
MMAC : 27.77 (+0.04%)
GRA : 69.99 (+0.03%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CORE, FCCY, KIN, MNR; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 18, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CORE : 45.65 (-0.76%)
FCCY : 27.79 (+3.81%)
KIN : 9.25 (+0.11%)
MNR : 19.30 (+1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify compounds and targets that have...

See More

Key Turning Points

3rd Resistance Point 9.28
2nd Resistance Point 9.27
1st Resistance Point 9.26
Last Price 9.25
1st Support Level 9.24
2nd Support Level 9.23
3rd Support Level 9.22

See More

52-Week High 9.28
Last Price 9.25
Fibonacci 61.8% 7.06
Fibonacci 50% 6.37
Fibonacci 38.2% 5.68
52-Week Low 3.46

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar